UniProt ID | CAPG_HUMAN | |
---|---|---|
UniProt AC | P40121 | |
Protein Name | Macrophage-capping protein | |
Gene Name | CAPG | |
Organism | Homo sapiens (Human). | |
Sequence Length | 348 | |
Subcellular Localization | Nucleus . Cytoplasm . Secreted . Melanosome . Identified by mass spectrometry in melanosome fractions from stage I to stage IV (PubMed:17081065). Redistributes throughout the cytoplasm during mitosis and is excluded from regions containing chromosome | |
Protein Description | Calcium-sensitive protein which reversibly blocks the barbed ends of actin filaments but does not sever preformed actin filaments. May play an important role in macrophage function. May play a role in regulating cytoplasmic and/or nuclear structures through potential interactions with actin. May bind DNA.. | |
Protein Sequence | MYTAIPQSGSPFPGSVQDPGLHVWRVEKLKPVPVAQENQGVFFSGDSYLVLHNGPEEVSHLHLWIGQQSSRDEQGACAVLAVHLNTLLGERPVQHREVQGNESDLFMSYFPRGLKYQEGGVESAFHKTSTGAPAAIKKLYQVKGKKNIRATERALNWDSFNTGDCFILDLGQNIFAWCGGKSNILERNKARDLALAIRDSERQGKAQVEIVTDGEEPAEMIQVLGPKPALKEGNPEEDLTADKANAQAAALYKVSDATGQMNLTKVADSSPFALELLISDDCFVLDNGLCGKIYIWKGRKANEKERQAALQVAEGFISRMQYAPNTQVEILPQGHESPIFKQFFKDWK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MYTAIPQS -------CCCCCCCC | 6.39 | 25944712 | |
2 | Phosphorylation | ------MYTAIPQSG ------CCCCCCCCC | 12.60 | 25106551 | |
3 | Phosphorylation | -----MYTAIPQSGS -----CCCCCCCCCC | 19.47 | 25106551 | |
8 | Phosphorylation | MYTAIPQSGSPFPGS CCCCCCCCCCCCCCC | 35.56 | 28450419 | |
10 | Phosphorylation | TAIPQSGSPFPGSVQ CCCCCCCCCCCCCCC | 28.72 | 25159151 | |
15 | Phosphorylation | SGSPFPGSVQDPGLH CCCCCCCCCCCCCCE | 19.49 | 28450419 | |
103 | Phosphorylation | REVQGNESDLFMSYF CCCCCCCCHHHHHHC | 43.54 | - | |
107 | Sulfoxidation | GNESDLFMSYFPRGL CCCCHHHHHHCCCCC | 4.06 | 30846556 | |
108 | Phosphorylation | NESDLFMSYFPRGLK CCCHHHHHHCCCCCC | 19.11 | - | |
115 | Acetylation | SYFPRGLKYQEGGVE HHCCCCCCCCCCCHH | 47.95 | 25953088 | |
115 | Ubiquitination | SYFPRGLKYQEGGVE HHCCCCCCCCCCCHH | 47.95 | - | |
116 | Phosphorylation | YFPRGLKYQEGGVES HCCCCCCCCCCCHHH | 19.48 | 28152594 | |
123 | Phosphorylation | YQEGGVESAFHKTST CCCCCHHHHCCCCCC | 33.55 | 28857561 | |
127 | 2-Hydroxyisobutyrylation | GVESAFHKTSTGAPA CHHHHCCCCCCCCCH | 37.40 | - | |
127 | Ubiquitination | GVESAFHKTSTGAPA CHHHHCCCCCCCCCH | 37.40 | - | |
128 | Phosphorylation | VESAFHKTSTGAPAA HHHHCCCCCCCCCHH | 23.97 | 28985074 | |
129 | Phosphorylation | ESAFHKTSTGAPAAI HHHCCCCCCCCCHHH | 29.64 | 25159151 | |
130 | Phosphorylation | SAFHKTSTGAPAAIK HHCCCCCCCCCHHHH | 42.46 | 26657352 | |
137 | 2-Hydroxyisobutyrylation | TGAPAAIKKLYQVKG CCCCHHHHHHHHCCC | 31.81 | - | |
137 | Ubiquitination | TGAPAAIKKLYQVKG CCCCHHHHHHHHCCC | 31.81 | - | |
137 | Acetylation | TGAPAAIKKLYQVKG CCCCHHHHHHHHCCC | 31.81 | 23749302 | |
143 | Ubiquitination | IKKLYQVKGKKNIRA HHHHHHCCCCCCCCC | 49.87 | - | |
143 | Succinylation | IKKLYQVKGKKNIRA HHHHHHCCCCCCCCC | 49.87 | 23954790 | |
151 | Phosphorylation | GKKNIRATERALNWD CCCCCCCCHHHHCCC | 19.02 | - | |
205 | Ubiquitination | RDSERQGKAQVEIVT HCCCCCCCCEEEEEE | 27.57 | - | |
212 | Phosphorylation | KAQVEIVTDGEEPAE CCEEEEEECCCCCHH | 43.90 | 28450419 | |
227 | Ubiquitination | MIQVLGPKPALKEGN HHHHHCCCHHHCCCC | 40.92 | - | |
231 | Ubiquitination | LGPKPALKEGNPEED HCCCHHHCCCCCHHC | 66.73 | - | |
231 | Acetylation | LGPKPALKEGNPEED HCCCHHHCCCCCHHC | 66.73 | 18526033 | |
243 | Acetylation | EEDLTADKANAQAAA HHCCCCHHHHHHHHH | 40.87 | 25953088 | |
243 | Ubiquitination | EEDLTADKANAQAAA HHCCCCHHHHHHHHH | 40.87 | 21906983 | |
253 | Ubiquitination | AQAAALYKVSDATGQ HHHHHHHHHHCCCCC | 35.79 | - | |
253 | 2-Hydroxyisobutyrylation | AQAAALYKVSDATGQ HHHHHHHHHHCCCCC | 35.79 | - | |
258 | Phosphorylation | LYKVSDATGQMNLTK HHHHHCCCCCCCCEE | 32.70 | - | |
261 | Sulfoxidation | VSDATGQMNLTKVAD HHCCCCCCCCEEECC | 4.73 | 21406390 | |
297 | Acetylation | CGKIYIWKGRKANEK CCEEEEECCCCCCHH | 39.00 | 26051181 | |
297 | Ubiquitination | CGKIYIWKGRKANEK CCEEEEECCCCCCHH | 39.00 | - | |
318 | Phosphorylation | QVAEGFISRMQYAPN HHHHHHHHHHCCCCC | 21.31 | 21712546 | |
322 | Phosphorylation | GFISRMQYAPNTQVE HHHHHHCCCCCCCEE | 18.06 | 26074081 | |
326 | Phosphorylation | RMQYAPNTQVEILPQ HHCCCCCCCEEECCC | 32.69 | 29507054 | |
337 | Phosphorylation | ILPQGHESPIFKQFF ECCCCCCCHHHHHHH | 20.02 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CAPG_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CAPG_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CAPG_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SIAH1_HUMAN | SIAH1 | physical | 25416956 | |
ADK_HUMAN | ADK | physical | 26344197 | |
COF1_HUMAN | CFL1 | physical | 26344197 | |
CRIP1_HUMAN | CRIP1 | physical | 26344197 | |
DAZP1_HUMAN | DAZAP1 | physical | 26344197 | |
ETFB_HUMAN | ETFB | physical | 26344197 | |
FUBP1_HUMAN | FUBP1 | physical | 26344197 | |
MIF_HUMAN | MIF | physical | 26344197 | |
PIR_HUMAN | PIR | physical | 26344197 | |
PRDX6_HUMAN | PRDX6 | physical | 26344197 | |
SNX3_HUMAN | SNX3 | physical | 26344197 | |
TKT_HUMAN | TKT | physical | 26344197 | |
UFC1_HUMAN | UFC1 | physical | 26344197 | |
UFM1_HUMAN | UFM1 | physical | 26344197 | |
KHDR2_HUMAN | KHDRBS2 | physical | 28514442 | |
HSP7C_HUMAN | HSPA8 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-337, AND MASSSPECTROMETRY. |